A phase III trial assessing SQX770 in patients with herpes labialis
Latest Information Update: 07 Aug 2019
At a glance
- Drugs Squaric acid dibutylester (Primary)
- Indications Herpes labialis
- Focus Therapeutic Use
Most Recent Events
- 07 Aug 2019 New trial record
- 05 Aug 2019 According to a Squarex media release, this trial will be initiated following a planned FDA end of phase 2 meeting later this year.